EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Epigenetic analyses suggest different pathways during pregnancy for development of type 1 diabetes in children with high versus low‐neutral human leukocyte antigen‐risk

Shamila D. Alipoor, Angelica Ahrens, Julia Åkesson, Thomas Hillerton, Mika Gustafsson, Maria Lerm, Johnny Ludvigsson

Journal of Internal Medicine · 2026-05 · 299 (5) · 570-586

DOI: 10.1111/joim.70077 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background and objective The development of Type 1 diabetes (T1D) is shaped by genetic predisposition and epigenetic regulation. Human leukocyte antigen (HLA) risk alleles are major genetic determinants, but the epigenetic landscape in relation to disease onset remains unclear. Early‐life epigenetic modifications may reveal how environmental and epigenetic factors interact in T1D pathogenesis. Methods We investigated epigenetic differences in cord blood DNA from individuals with different HLA risk alleles who later developed T1D using epigenome‐wide association studies. Result High‐risk HLA carriers showed differentially methylated genes (DMGs) mainly involved in immune and autoimmune processes, resembling patterns in other autoimmune diseases. In contrast, low‐to‐neutral risk carriers exhibited DMGs linked to signaling cascades, metabolic pathways, and Type 2 diabetes–related mechanisms such as beta cell function and insulin signaling. Conclusion These findings indicate that heterogeneity in T1D pathogenetic mechanisms based on HLA background may influence disease development.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →